Trends and Insights

Certain patients with type 2 diabetes (T2D) may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease (AD), according to a study conducted at and published recently in Molecular Aspects of Medicine. Researchers led by Giulio Maria Pasinetti, MD, PhD, of the Icahn School of Medicine at Mount Sinai...

For the first time, researchers have identified how type 2 diabetes (T2D) affects lymphatic vessels — a finding that could lay the groundwork for new therapies to improve the lives of people with the condition, according to a study recently published in Cardiovascular Research. The scientists, led by Joshua Scallan, PhD, of the University of...

Periodic telephone counseling can be a highly effective, low-cost tool for lowering blood-sugar levels in minority, urban adults with uncontrolled diabetes, according to a study recently published in the American Journal of Preventive Medicine. Researchers led by Elizabeth A. Walker, PhD, RN, of the Albert Einstein College of Medicine in New York analyzed 941 adults...

Laparoscopic adjustable band (LAGB) surgery and an intensive medical diabetes and weight management (IMWM) program have similar one-year benefits on diabetes control, cardiometabolic risk, and patient satisfaction, according to a study recently published in the Journal of Clinical Endocrinology & Metabolism. Researchers led by Allison B. Goldfine, MD, of the Joslin Diabetes Center at Harvard...

Beta Blockers May Lessen Risperidone-Induced Bone Loss A recent mouse study has shown that beta blockers could reduce bone loss caused by the atypical antipsychotic (AA) drug risperidone (RIS). The study was published recently in Endocrinology. Researchers led by Katherine J. Motyl, PhD, of the Maine Medical Center Research Institute in Scarborough, and Karen L....

Mouse Model Pathways Could Predict Prostate Cancer Progression Researchers have used mouse models to examine the complex interplay of several pathways to predict prostate cancer (PCa) progression, which can be diffi cult to analyze in humans. The study was published recently in Hormones and Cancer. The investigators, led by Diane M. Robins, PhD, of the...

People who live at altitudes above 1,500 meters tend to have a lower fasting glycemia and better glucose tolerance compared to those who live closer to sea level, and understanding why that is could lead to new therapeutic options, according to a study recently published in Endocrine Reviews. Researchers led by Orison O. Woolcott, MD,...

United States Most Expensive Place to Have T2D People with type 2 diabetes in the U.S. have the highest healthcare costs to treat the disease in the world, according to a recent study published in PharmacoEconomics. The lifetime price tag to treat T2D in the U.S. is around $283,000, even higher than in other countries...